Hepatoblastoma (HB) is the most common pediatric liver malignancy; however, hereditary
predisposition and acquired molecular aberrations related to HB clinicopathological …

In contrast with adults, about two-thirds of hepatic tumors in children are malignant. The
2014 international consensus classification of pediatric liver tumors is shown in Box 1 …

Abstract Purpose of Review As the most common pediatric primary liver cancer with rising
incidence, hepatoblastoma remains challenging to treat. Here, we review the current …

Objective Hepatoblastoma (HB) is the most common pediatric primary malignant liver tumor,
its incidence has been increasing worldwide, but recent changes in incidence and outcomes …

Background In response to hypoxia, tumor cells undergo transcriptional reprogramming
including upregulation of carbonic anhydrase (CA) IX, a metalloenzyme that maintains acid …

Background & Aims Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the
predominant liver cancers in children, though their respective treatment options and …

Two percent of pediatric malignancies arise primarily in the liver; roughly 60% of these
cancers are hepatoblastoma (HB). Despite the rarity of these cases, international …

Liver tumors account for approximately 1%–2% of all pediatric malignancies, with the two
most common tumors being hepatoblastoma (HB) and hepatocellular carcinoma (HCC) …

Simple Summary Hepatoblastoma is the most common malignant liver tumor in children.
Small cell undifferentiated histology and low alpha-fetoprotein have been previously …

Objective After a complete remission to treatment for hepatoblastoma, some children still
have recurrence. We identified and explored the factors that influence recurrence after …